Identification of BCSCs from tumor samples and breast cancer cells relies mainly on CD44+/CD24– or ALDH phenotypes (Ginestier et al., 2007; Fillmore and Kuperwasser, 2008; Gupta et al., 2009). This evidence concerns the gene CD44 and breast cancer.